公司调查 - Halper Sadeh LLC正在调查City Office REIT Inc (NYSE: CIO)以每股7美元现金出售给MCME Carell Holdings LP及MCME Carell Holdings LLC的交易是否存在违反联邦证券法或违背股东信托义务的行为 [1] - 同时调查Colony Bankcorp Inc (NYSE: CBAN)与TC Bancshares Inc的合并交易 [2] 股东权益行动 - 律师事务所可能代表股东寻求更高对价、更充分交易信息披露或其他补偿方案 [2] - 采用风险代理收费模式 股东无需预先支付法律费用 [2] 法律服务范围 - 该律所专门代理全球范围内遭受证券欺诈及公司不当行为侵害的投资者 [3] - 已成功帮助投资者追回数百万美元损失并推动公司治理改革 [3] 联系方式 - 股东可通过电话(212) 763-0060或指定邮箱联系Daniel Sadeh/Zachary Halper律师 [3][4] - 官网提供更多信息 https://www.halpersadeh.com [4]

PHILADELPHIA, July 24, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm announces it is investigating potential securities fraud claims involving Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ: WOOF), following the recent filing of a federal securities class action lawsuit.The complaint alleges that Petco made false and misleading statements about the sustainability of its pandemic-driven growth and premium product strategy. These alleged misstateme ...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against RxSight, Inc. (“RxSight” or “the Company”) (NASDAQ: RXST) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired RxSight securiti ...

公司调查 - 律师事务所Portnoy Law Firm对KinderCare Learning Companies Inc展开证券欺诈调查 可能代表投资者提起集体诉讼 [1] - 调查重点为KinderCare是否发布重大虚假或误导性陈述 或未披露关键投资者信息 [2] - 律师事务所创始人曾为受损投资者追回超过55亿美元资金 [5] 财务表现 - KinderCare 2024年第四季度运营亏损8930万美元 较上年同期4870万美元利润出现重大逆转 [3] - 亏损主因包括股权激励费用增加及COVID-19相关补贴减少 [3] - 公司2025年财务指引低于市场预期 导致次日股价下跌22.17% [4] 投资者行动 - 受损投资者可联系Lesley Portnoy律师进行免费案件评估 探讨索赔方案 [1][2] - 律师事务所提供法律权利咨询 协助投资者追回损失 [2][5]

公司动态 - Replimune Group Inc 收到美国食品药品监督管理局(FDA)关于RP1(vusolimogene oderparepvec)联合nivolumab治疗晚期黑色素瘤的生物制品许可申请(BLA)的完全回复函(CRL) [3] - FDA认为IGNYTE试验未能提供足够有效性的实质性证据 因此拒绝批准该申请 [4] - 公司股价在消息公布后暴跌9 52美元 跌幅超过77% 收盘价为2 80美元(2025年7月22日) [4] 法律进展 - Portnoy Law Firm已对Replimune可能存在的证券欺诈行为展开调查 并考虑代表投资者提起集体诉讼 [1] - 该律所创始合伙人曾为受损投资者追回超过55亿美元赔偿 [5] - 受损失投资者可通过电话310-692-8883或邮箱info@portnoylaw.com联系Lesley Portnoy律师进行免费案件评估 [2][5]

SAN DIEGO, July 24, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP, announces that a class action lawsuit has been filed on behalf of investors who purchased or acquired Reddit, Inc. (“Reddit” or the “Company”) (NYSE: RDDT) securities between October 29, 2024 and May 20, 2025, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than August 18, 2025. If you have incurred significant losses and want to act as the lead plaintiff in ...

诉讼背景 - 领先证券律师事务所Bleichmar Fonti & Auld LLP宣布对Centene Corporation及其部分高管提起集体诉讼 指控其涉嫌违反联邦证券法 [1] - 诉讼依据为《1934年证券交易法》第10(b)和20(a)条款 代表购买Centene证券的投资者发起 案件由美国纽约南区地方法院受理 案件编号25-cv-05659 [2] 公司业务概况 - Centene是一家专注于政府资助医疗计划(如Medicaid和Medicare)的医疗保险公司 同时通过健康保险市场为《平价医疗法案》参保者提供服务 [3] 财务指引争议 - 2024年12月12日公司发布2025财年指引 称其"在空前阻力下保持盈利稳定性" 2025年2月4日因参保人数"超预期"上调指引 4月25日再次以参保增长和保留率为由提高指引 [4] - 实际情况显示 Centene服务的主要市场参保增长率低于预期 且疾病发病率(morbidity rates)高于预期 [4] 股价暴跌事件 - 2025年7月1日公司突然撤回先前指引 因独立精算报告显示其服务的29个州中22个州市场增长低于预期 这些州的发病率显著高于预期 [5] - 消息公布后股价从7月1日的56.65美元/股暴跌40%至7月2日的33.78美元/股 单日下跌22.87美元 [5] 律所背景 - 代理律所BFA在证券集体诉讼领域具有国际领先地位 曾为特斯拉董事会案件追回9亿美元 为Teva制药案件追回4.2亿美元 [7][8]

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Hims & Hers, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/hims-hers-health-inc-class-action. Investors have until August 25, 2025, to ask th ...

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Sarepta Therapeutics, Inc. (NASDAQ: SRPT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Sarepta, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/sarepta-therapeutics-inc-class-action. Investors have until August 25, 2025, to as ...

SAN DIEGO, July 24, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that holders of Broadmark Realty Capital Inc. (NYSE: BRMK) common stock as of the record date of the May 2023 merger between Broadmark and Ready Capital Corporation (NYSE: RC) (the "Merger"), have until Monday, July 28, 2025 to seek appointment as lead plaintiff of the Broadmark class action lawsuit.  Captioned Grant v. Broadmark Realty Capital, No. 25-cv-01013 (W.D. Wash.), the Broadmark class action lawsuit ...